1. Mesoporous Silica Nanoparticle-Based Combination of Niclosamide and Doxorubicin: Effect of Treatment Regimens on Breast Cancer Subtypes
    Garima Lohiya et al, 2021, ACS Appl. Bio Mater. CrossRef
  2. null
    Jonaid Ahmad Malik et al, 2022 CrossRef
  3. Nanoparticle-based Olaparib delivery enhances its effect, and improves drug sensitivity to cisplatin in triple negative breast cancer
    Shentao Zhang et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
  4. Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide
    Patricia Cámara-Sánchez et al, 2022, IJMS CrossRef
  5. Combination of niclosamide and current therapies to overcome resistance for cancer: New frontiers for an old drug
    Junyi Ren et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  6. Disturbance of the Warburg effect by dichloroacetate and niclosamide suppresses the growth of different sub-types of malignant pleural mesothelioma in vitro and in vivo
    Sze-Kwan Lam et al, 2022, Front. Pharmacol. CrossRef
  7. Preparation and pharmacodynamics of Niclosamide-hydroxypropyl-β-cyclodextrin inclusion complex
    Lukuan Liu et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
  8. Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases
    Zhan Wang et al, 2022, IJMS CrossRef
  9. Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease
    Alf Spitschak et al, 2022, Pharmaceutics CrossRef
  10. Niclosamide causes lysosome-dependent cell death in endometrial cancer cells and tumors.
    Rajani Rai et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  11. Niclosamide inhibits epithelial-mesenchymal transition with apoptosis induction in BRAF/ NRAS mutated metastatic melanoma cells
    Sowjanya Thatikonda et al, 2023, Toxicology in Vitro CrossRef
  12. Primary assessment of medicines for expected migrastatic potential with holographic incoherent quantitative phase imaging
    Markéta Šuráňová et al, 2023, Biomed. Opt. Express CrossRef
  13. Chemical mixture that targets the epidermal growth factor pathway impairs human trophoblast cell functions
    Anita A. Waye et al, 2024, Toxicology and Applied Pharmacology CrossRef
  14. Androgen receptor: Structure, signaling, function and potential drug discovery biomarker in different breast cancer subtypes
    Nirali Shukla et al, 2024, Life Sciences CrossRef
  15. null
    Ajay K. Singh et al, 2024 CrossRef